Session » Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases I: Focus on Auto-Inflammatory Diseases (0777–0782)
- 1:00PM-1:15PM
-
Abstract Number: 0777
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI)
- 1:15PM-1:30PM
-
Abstract Number: 0778
Clinical significance of non-infectious increased procalcitonin in Still’s disease: A predictor of macrophage activation syndrome
- 1:30PM-1:45PM
-
Abstract Number: 0779
Interim Results of a Randomized Placebo Controlled Study of IL-1 Inhibitor Goflikicept in Patients With Familial Mediterranean Fever
- 1:45PM-2:00PM
-
Abstract Number: 0780
Baseline Pharmacodynamic Markers and Response to Emapalumab in Children and Adults with Macrophage Activation Syndrome (MAS) in Still’s Disease: Results from a Pooled Analysis of Two Prospective Trials
- 2:00PM-2:15PM
-
Abstract Number: 0781
Comprehensive mass cytometry analyses of disease-related cells in adult-onset Still’s disease
- 2:15PM-2:30PM
-
Abstract Number: 0782
Expansion of T-bet⁺ Age-Associated B Cells Is Associated with Clinical Complications in Still’s Disease